granisetron and Cancer of Ovary

granisetron has been researched along with Cancer of Ovary in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (61.11)18.2507
2000's5 (27.78)29.6817
2010's1 (5.56)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y1
Fujiwara, K; Katakami, N; Kitao, A; Matsumoto, K; Minami, H; Morita, S; Negoro, S; Shibata, N; Tanioka, M; Yamaguchi, S1
Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K1
Bagaméri, A; Lehoczky, O; Pulay, T; Udvary, J1
Buchanan, D; Muirhead, K1
Böhm, S; Bresciani, G; Oriana, S1
Eguchi, F; Emoto, M; Hachisuga, T; Kawarabayashi, T; Mohtai, H; Shindo, M; Shirakawa, K1
Fujii, T; Kioka, H; Naito, H; Nakagawa, H; Nakata, N; Tanimoto, H; Tanioka, Y1
Fukunaka, N; Ishioka, S; Itoh, E; Kitajima, Y; Kudo, R; Sagae, S; Sato, K1
Kitada, M; Sawaragi, I1
Rodenburg, CJ; Slee, PH1
Akutagawa, N; Fukunaka, N; Hayashi, T; Kitajima, Y; Kudo, R; Mizumoto, H; Nakamura, T; Sagae, S; Sugimura, M; Terasawa, K; Wataba, K; Yamana, K1
Cheng, X; Itamochi, H; Kigawa, J; Minagawa, Y; Okada, M; Terakawa, N1
Aoki, Y; Endo, M; Furue, H; Hanaoka, J; Honma, S; Kodama, S; Maruhashi, T; Oshima, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yoshiya, N1
Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K1
Fujiwara, K; Ishikawa, H; Kohno, I; Nagaji, M; Suzuki, S; Yamauchi, H1
Goram, AL; Richmond, PL1
Nakayama, S; Noda, T; Torii, Y1

Trials

14 trial(s) available for granisetron and Cancer of Ovary

ArticleYear
A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy.
    British journal of cancer, 2013, Aug-20, Volume: 109, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Camptothecin; Carboplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Endometrial Neoplasms; Female; Granisetron; Humans; Irinotecan; Logistic Models; Middle Aged; Morpholines; Neoplasms; Ovarian Neoplasms; Temperance; Treatment Outcome; Vomiting

2013
Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
    Oncology, 2003, Volume: 64, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Droperidol; Drug Therapy, Combination; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Premedication; Uterine Neoplasms; Vomiting

2003
Does increasing the steroid dose enhance the efficacy of the antiemetic combination of granisetron and methylprednisolone in gynecologic cancer patients--a randomized study.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Mar-15, Volume: 113, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Endometrial Neoplasms; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Ovarian Neoplasms; Prospective Studies; Treatment Outcome; Vomiting

2004
Control of nausea and vomiting by granisetron in ovarian cancer patients treated with different cisplatin-based regimens.
    Tumori, 1994, Oct-31, Volume: 80, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Granisetron; Humans; Nausea; Ovarian Neoplasms; Treatment Outcome; Vomiting

1994
[The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:2

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clonazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting

1995
[Antiemetic efficacy of the repeated use of granisetron in multiple cycles of anti-cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:16

    Topics: Carboplatin; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting

1994
[Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1996
Venous thrombosis as a complication of antiemetic treatment.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Thrombophlebitis; Vomiting

1996
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:6

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1997
Combination effect of granisetron and methylprednisolone for preventing emesis induced by cytotoxic agents.
    Gynecologic and obstetric investigation, 1997, Volume: 43, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Granisetron; Humans; Hydroxyindoleacetic Acid; Methylprednisolone; Metoclopramide; Middle Aged; Ovarian Neoplasms; Vomiting

1997
[Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Tablets; Uterine Neoplasms; Vomiting

1997
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:6

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1998
[Optimal timing of granisetron administration for the prevention of carboplatin-induced acute emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:14

    Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ovarian Neoplasms; Pilot Projects; Prospective Studies; Time Factors; Uterine Neoplasms; Vomiting, Anticipatory

1999
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory

2001

Other Studies

4 other study(ies) available for granisetron and Cancer of Ovary

ArticleYear
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4

    Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting

2021
Intractable nausea and vomiting successfully related with granisetron 5-hydroxytryptamine type 3 receptor antagonists in Palliative Medicine.
    Palliative medicine, 2007, Volume: 21, Issue:8

    Topics: Antiemetics; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Palliative Care; Treatment Outcome; Vomiting

2007
[The prevention of CDDP-induced emesis with granisetron].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:8

    Topics: Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1993
Pegylated liposomal doxorubicin: tolerability and toxicity.
    Pharmacotherapy, 2001, Volume: 21, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diphenhydramine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Hematologic Diseases; Humans; Liposomes; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Paresthesia; Premedication; Prochlorperazine; Ranitidine; Stomatitis; Tamoxifen; Treatment Failure

2001